Use of (DPP-4) inhibitors linked to increased risk of IBD : BMJ Anjali Nimesh Nimesh21 March 2018 7:31 PM ISTDipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new type of diabetes drug that lower high blood sugar levels. They are usually prescribed...
Diabetes management during Air travel - Key Recommendations Medha Baranwal Baranwal25 April 2018 8:30 PM ISTPatients affected by Diabetes require timely administration of antihyperglycemic therapy and have to face unique challenges during air travel. Various...
Sulfonylureas, Insulin increase heart disease risk in diabetes : JAMA Medha Baranwal Baranwal23 Dec 2018 8:10 PM ISTChicago, Illinois: Two drugs — sulfonylureas and basal insulin -- commonly prescribed as second-line antidiabetic medication therapy, carry a high...
DPP-4 inhibitors may increase risk of aspiration pneumonia Medha Baranwal Baranwal24 Dec 2019 8:20 PM ISTJapan: Glucose-lowering DPP-4 inhibitors are expected to prevent dysphagia and aspiration pneumonia due to their role in preventing the degradation of...
These antidiabetic drugs may lead to bile duct cancer Medha Baranwal Baranwal9 Dec 2018 8:28 PM ISTCanada: DPP-4 inhibitors and GLP-1 receptor agonists, used for the treatment of type 2 diabetes (T2D), are associated with an increased risk of...
